PL Developments is a leading manufacturer of over-the-counter (OTC) pharmaceutical products and consumer healthcare goods, offering a wide array of generic products for major retailers. In 2026, the company holds 80 Abbreviated New Drug Applications (ANDAs), with additional products in the regulatory pipeline.
For companies focused on speed to market, leveraging an existing approved NDA or ANDA can provide a faster path to commercialization by eliminating years of development while providing a proven regulatory and manufacturing foundation.